written on 01.05.2014

Next deal up for Merck: Selling $15 billion worth of older brands


With its consumer unit apparently on the verge of a sale, Merck is weighing its next asset disposal. <em>Reuters</em> sources say that the U.S.-based drugmaker may unload $15 billion worth of older drugs, in a move that would mirror previous sell-offs by GlaxoSmithKline–and an in-the-works Sanofi deal.